Nimbus Therapeutics Revenue and Competitors

Boston, MA USA

Location

$302M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Nimbus Therapeutics's estimated annual revenue is currently $18.8M per year.(i)
  • Nimbus Therapeutics's estimated revenue per employee is $155,000
  • Nimbus Therapeutics's total funding is $302M.

Employee Data

  • Nimbus Therapeutics has 121 Employees.(i)
  • Nimbus Therapeutics grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.2M10%N/AN/A
#3
$4.2M2735%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$1.4M929%N/AN/A
#6
$235M255-31%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.3M340%N/AN/A
#10
$1.9M12-8%N/AN/A
Add Company

Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Massachusetts (USA). With its breakthrough computational chemistry platform, enabled through its privileged partnership with co-founder, Schrödinger, Inc., Nimbus is pioneering the application of computational chemistry to design treatments for substantial and underserved human diseases. The company?s focus on metabolic diseases, cancer and immune-inflammatory disorders reflects the mechanistic relationship between these disorders, and Nimbus? ability to rapidly tackle well validated targets as well as those that have proven intractable to the approaches taken by others in the pharmaceutical and biotechnology industry, resulting in medicines with high potency, selectivity and other desirable drug-like properties.

keywords:N/A

$302M

Total Funding

121

Number of Employees

$18.8M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Nimbus Therapeutics News

2022-04-20 - Global Computational Medicine and Drug Discovery Software ...

Entelos, Compugen, Genedata, Biognos Ab, Chemical Computing Group, Crown Bioscience, Rhenovia Pharma Limited, Leadscope, Schrodinger, Nimbus Therapeutics,...

2022-04-06 - Nimbus Therapeutics Strengthens Clinical Development ...

Nimbus Therapeutics Strengthens Clinical Development Leadership Team. Published: Apr 13, 2022. April 13, 2022 11:00 UTC. CAMBRIDGE, Mass.

2022-03-30 - Nimbus Therapeutics Presents Preclinical Data on Cbl-b ...

Nimbus Therapeutics is a clinical-stage company that designs and develops breakthrough medicines through its powerful and comprehensive...

2021-07-13 - Nimbus Therapeutics : Announces $105 Million Private Financing to Advance Pipeline Including Multiple Clinical Programs

Nimbus Therapeutics, a biotechnology company designing breakthrough medicines through structure-based drug discovery and development, today announced the closing of a $105 million private financing round. The round was led by BVF Partners L.P. (BVF), with participation from existing investors in ...

2018-06-05 - Biotech Company Nimbus Therapeutics Secures $65M in Funding

Nimbus Therapeutics, a Cambridge, Massachusetts-based biotechnology company, secured $65m in funding. Backers included Atlas Venture, SR One, Lilly Ventures, Bill Gates, Pfizer Venture Investments, Lightstone Ventures and Schrödinger. The company intends to use the funds to accelerate its pipe ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18.8M121-15%N/A
#2
$3.5M1218%N/A
#3
$12.3M121-3%N/A
#4
$22M12212%N/A
#5
$39.4M1228%N/A